Given that EVs released by cancer cells with disrupted Ca2+ signalling can exhibit enhanced metastatic capacity (Lee et al., 2020; Messenger et al., 2018), we hypothesized that EVs induced by TRPC3 activation may contribute to OC tumorigenesis through enhancing cell proliferation. This evidence concerns the gene TRPC3 and cancer.